All Perspectives, One Place.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Pope Leo XIV
Mother's Day
Pope Francis
Artificial Intelligence
Catholic Church
Social Media
Donald Trump
Vatican
World War II
Stock Markets
Tariffs
European Union
Published • loading... • Updated

Embattled TAVR Device Myval Meets Expectations in Trial, but Trouble Still Ahead

Summary by MedPage Today
(MedPage Today) -- For a balloon-expandable transcatheter aortic valve replacement (TAVR or TAVI) platform, the much-litigated Myval performed well enough in the COMPARE-TAVI 1 randomized trial, but its rates of pacemakers and paravalvular leaks...

2 Articles

All
Left
Center
1
Right
MedPage TodayMedPage Today
Reposted by
Anti-Aging, Acupuncture and Health NewsAnti-Aging, Acupuncture and Health News
Center

Embattled TAVR Device Myval Meets Expectations in Trial, but Trouble Still Ahead

(MedPage Today) -- For a balloon-expandable transcatheter aortic valve replacement (TAVR or TAVI) platform, the much-litigated Myval performed well enough in the COMPARE-TAVI 1 randomized trial, but its rates of pacemakers and paravalvular leaks...

·New York, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Anti-Aging, Acupuncture and Health News broke the news in on Friday, April 4, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
SearchBlindspotLocal